Indication
Brain-dead Organ Donors
1 clinical trial
2 products
Clinical trial
Evaluation of the Hemodynamic Stability of Potassium Canrenoate in Brain-dead Organ Donors: Randomized Controlled Clinical TrialStatus: Recruiting, Estimated PCD: 2024-02-26
Product
Potassium CanrenoateProduct
IV Sodium Chloride